SURAKSHA DIAGNOSTIC
Back to Cashflow Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-35 Cr | ₹-21 Cr | ₹-44 Cr | ₹-28 Cr | ₹-20 Cr |
What is the latest Cash Flow from Investing Activities ratio of SURAKSHA DIAGNOSTIC ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-35 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-44 Cr |
Mar2021 | ₹-28 Cr |
Mar2020 | ₹-20 Cr |
How is Cash Flow from Investing Activities of SURAKSHA DIAGNOSTIC Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-35 Cr | Negative | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-44 Cr | Negative | |
Mar2021 | ₹-28 Cr | Negative | |
Mar2020 | ₹-20 Cr | - |
Compare Cash Flow from Investing Activities of peers of SURAKSHA DIAGNOSTIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SURAKSHA DIAGNOSTIC | ₹1,590.1 Cr | -4.6% | -12.7% | NA | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹123,200.0 Cr | 4.2% | 2.4% | 34.2% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹105,899.0 Cr | 0.8% | 4.6% | 15.2% | Stock Analytics | |
FORTIS HEALTHCARE | ₹63,926.1 Cr | 6.1% | 8.6% | 69.2% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹40,514.5 Cr | 1.7% | -4% | 58.5% | Stock Analytics | |
GLOBAL HEALTH | ₹35,550.3 Cr | 0.3% | 17.2% | 11.5% | Stock Analytics |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SURAKSHA DIAGNOSTIC | -4.6% |
-12.7% |
|
SENSEX | -0.1% |
0.2% |
2.1% |
You may also like the below Video Courses